New neuroimaging and bioinformatics tools for predicting psychotic disorders

NewsGuard 100/100 Score

A new EU project, METSY, develops and applies neuroimaging and bioinformatics tools to study how lipid metabolism is connected to psychotic disorders and metabolic co-morbidities such as metabolic syndrome and diabetes.

The overall objective is to identify, prioritize and evaluate multi-modal blood and neuroimaging biomarkers that have diagnostic potential for prediction and monitoring psychotic disorders and associated metabolic co-morbidities. The consortium brings together clinicians, researchers and industry partners in the domains of psychiatry, neuroimaging, metabolic research, systems biology and bioinformatics.

The 4-year EU-project is coordinated by Research Professor Matej Orešič from VTT Technical Research Centre of Finland. Total budget for the project is € 5.94 million €, of which the EU's share is € 4.23 million.

Source: VTT Technical Research Centre of Finland

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New animation series launched to improve parental understanding of brain development in premature infants